ARTERIOCYTE MEDICAL SYSTEMS, INC.
HOPKINTON, MA

ArterioCyte Medical Systems, Inc., originally based in Hopkinton, Massachusetts, has been a pioneering company in the medical device industry since its inception by Arteriocyte, Inc. and DW Healthcare Partners in July 2007. Known for addressing critical unmet needs across cardiac, orthopedic, and vascular surgeries, the company developed innovative products designed to enhance patient recovery times. Key among these offerings is the market-leading MAGELLAN Autologous Platelet Separator. Following a strategic acquisition by Isto Holdings, ArterioCyte became part of Isto Biologics, headquartered in St. Louis with operational ties still maintained in Massachusetts. This merger aimed to integrate cutting-edge biologics platforms and expand the range within spine, orthopedics, and functional medicine markets, thereby supporting value-based healthcare. As an incorporated entity originally in Delaware but operating substantially from Hopkinton, Florida (with a registered office at 45 South Street, Suite C, Hopkinton, MA), the company holds the filed number F10000003086. It operates as a For-Profit Corporation, with its most recent renewal event on August 9, 2021. Contact can be made via multiple phone lines, and further information is available at arteriocytemedicalsystems.com. Leading the organization through this transition are key figures such as Donald Brown in the role of Chief Executive Officer and Harry Holiday as Director. Together with other executives like Jesse Klein, VP, they drive ArterioCyte Medical Systems’ mission to deliver exceptional medical solutions backed by expert scientific knowledge in biologics and cell therapy.